Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Drospirenone Tablets (RLD Slynd) had estimated annual sales of US $141 million in the US
Glenmark’s Sodium Phenylbutyrate Tablets USP, 500 mg, will be distributed in the U.S. by Glenmark Pharmaceuticals USA.
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of US $112 million in the US
Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Subscribe To Our Newsletter & Stay Updated
